Aethlon Medical Inc (AEMD)

[bbarry]

A brief summary of 8 disclosures from presentation

This info will no doubt be available later when these new powerpoints are accessible on Aethlons’s website. But here is a quick summary. Please excuse the typos.

8 disclosures

1.) a new research study on Breast Cancer. Dr Doug Taylor Univ. Louisville
data expected within 60 days

2.) new study in process, in vitro study of Lymphoma

3.) a compassionate care case, involving EndStage Lunch Cancer Human patient at hosital in South Africa. Results still to be analyzed

4.) A tuberculosis study. Funded by Gates Foundation Grant
In Vitro study showed 97% capture of TB exsomes within 4 hours

5.) India: Drug Controller (gov’t agency) has cleared Hemopurifier for import

6.) India: recent GMP production run, 100 cartridges shipped

7.) India: announced work with Medanta Center: a new Medical Tourism Institution
- a $360M facility
- 1600 beds
- (I missed the figure) I think it was 20 operating rooms, or something like that
- 10 minutes from New Delhi airport
- add’l disclosures coming
8.) a Manufacturing Partnership: Membrana Gmbh based in Germany
we have letter of intent signed. Very large scale manufacturer of dialysis equipment.
Membrana is a division of PolyPore International (NYSE: PPO)
Aethlon retains control of all Intellectual Property
Partnership will provide scalable production upwards to very large numbers of units

That last slide included a mention of Membrana providing clinical trial support in EU

If I’ve missed key points on these disclosures, please add or correct.

Sure seems like it was a very great presentation, with a lot of substantive milestones, on multiple fronts.

Great day for all patient longs
BBarry